Latest Abiomed (ABMD) Headlines
Coverage on Covance Initiated - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 2:20PM CST
On Mar 06, 2014, we initiated coverage on Covance.
Cyberonics Upped to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 2:10PM CST
On Feb 26, 2014, Zacks Investment Research upgraded Cyberonics Inc. to a Zacks Rank #2 (Buy).
Teleflex Beats on Q4 Earnings, Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 12:50PM CST
Following the favorable earnings announcement, shares of Teleflex rose 0.8% till the last closing date.
BioScrip Down on Q4 Loss, Poor Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 10:30AM CST
BioScrip recently declared its fourth-quarter 2013 results.
Q4 Earnings Beat at AmSurg, Poor Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 9:10AM CST
AmSurg Corp.'s fourth-quarter 2013 EPS from continuing operations climbed 22% year over year to 60 cents.
Weakness Seen in Tenet Healthcare (THC): Stock Tumbles 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 7:56AM CST
Tenet Healthcare Corp. (THC) saw a big move last session. This breaks the recent trend of the company, as the stock is now trading below the volatile price range of $44.07 to $48.33 in the past one-month time frame.
Balanced View on Omnicell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 1:50PM CST
On Feb 24, 2014, we issued an updated research report on Omnicell.
DexCom Beats, Sees Narrower Q4 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 8:40AM CST
Owing to narrower reported loss or adjusted earnings in the 2013-fourth quarter, shares of Dexcom rose 3.5% since the announcement of earnings results
Wider Q4 Loss, Poor Outlook at Volcano Corp. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 8:00AM CST
Volcano Corporation reported adjusted net loss of 29 cents per share in the fourth quarter of 2013, wider than the Zacks Consensus Estimate loss of 24 cents per share.
Balanced View on PetMed - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 5:00PM CST
On Feb 19, 2014, we issued an updated research report on PetMed Express.
Updated Research Report on Cepheid - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 2:00PM CST
Recently, we issued an updated research report on Cepheid.
Why Cynosure (CYNO) Has A Bright Short-Term Future? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 7:54AM CST
Cynosure has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy
Sirona Dental Earnings Beat by a Penny, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 1:56PM CST
For fiscal 2014, SIRO retained its revenue and earnings guidance.
Thoratec Earnings Meet Ests but Fall Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 12:25PM CST
THOR's revenues in the quarter declined marginally by 0.2% to $128.2 million
Q1 Earnings Beat & Revs in Line at Hologic - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 05, 2:10PM CST
Hologic Inc. reported adjusted earnings of 34 cents per share in the first quarter of fiscal 2014.
Luminex Earnings Beat but Fall Y/Y, Shares Down - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 05, 9:34AM CST
The decline in earnings can be attributable to lower revenues and higher costs during the quarter.
Abiomed to Present at the Leerink Global Healthcare Conference 2014
GlobeNewswire - Wed Feb 05, 7:00AM CST
Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer will present at the Leerink Global Healthcare Conference 2014, February 12 at 1:00 p.m. EST. The conference will be held at The Waldorf Astoria Hotel in New York City, New York.
Medical Technology Veterans Program is renamed the MedTech and BioTech Veterans Program (MVP) and Expands Nationwide
GlobeNewswire - Wed Feb 05, 7:00AM CST
- Offers Advanced Educational Resources and Training for Veteran Recruits
Accuray Sees Narrower Loss, Hits 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 03, 11:57AM CST
Accuray posted a much narrower loss of $5.4 million, or 7 cents per share for the quarter compared with a loss of $25.5 million, or 35 cents per share for the same quarter in the prior fiscal year
Accuray (ARAY) Catches Eye: Stock Jumps 15.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 03, 8:04AM CST
Accuray Incorporated was a big mover last session, as the company saw its shares rise over 15% on the day.
Coverage on Covance Initiated - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 2:20PM CST
On Mar 06, 2014, we initiated coverage on Covance.
Cyberonics Upped to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 2:10PM CST
On Feb 26, 2014, Zacks Investment Research upgraded Cyberonics Inc. to a Zacks Rank #2 (Buy).
Teleflex Beats on Q4 Earnings, Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 12:50PM CST
Following the favorable earnings announcement, shares of Teleflex rose 0.8% till the last closing date.
BioScrip Down on Q4 Loss, Poor Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 10:30AM CST
BioScrip recently declared its fourth-quarter 2013 results.
Q4 Earnings Beat at AmSurg, Poor Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 9:10AM CST
AmSurg Corp.'s fourth-quarter 2013 EPS from continuing operations climbed 22% year over year to 60 cents.
Weakness Seen in Tenet Healthcare (THC): Stock Tumbles 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 7:56AM CST
Tenet Healthcare Corp. (THC) saw a big move last session. This breaks the recent trend of the company, as the stock is now trading below the volatile price range of $44.07 to $48.33 in the past one-month time frame.
Balanced View on Omnicell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 1:50PM CST
On Feb 24, 2014, we issued an updated research report on Omnicell.
DexCom Beats, Sees Narrower Q4 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 8:40AM CST
Owing to narrower reported loss or adjusted earnings in the 2013-fourth quarter, shares of Dexcom rose 3.5% since the announcement of earnings results
Wider Q4 Loss, Poor Outlook at Volcano Corp. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 8:00AM CST
Volcano Corporation reported adjusted net loss of 29 cents per share in the fourth quarter of 2013, wider than the Zacks Consensus Estimate loss of 24 cents per share.
Balanced View on PetMed - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 5:00PM CST
On Feb 19, 2014, we issued an updated research report on PetMed Express.
Updated Research Report on Cepheid - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 2:00PM CST
Recently, we issued an updated research report on Cepheid.
Why Cynosure (CYNO) Has A Bright Short-Term Future? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 7:54AM CST
Cynosure has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy
Sirona Dental Earnings Beat by a Penny, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 1:56PM CST
For fiscal 2014, SIRO retained its revenue and earnings guidance.
Thoratec Earnings Meet Ests but Fall Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 12:25PM CST
THOR's revenues in the quarter declined marginally by 0.2% to $128.2 million
Q1 Earnings Beat & Revs in Line at Hologic - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 05, 2:10PM CST
Hologic Inc. reported adjusted earnings of 34 cents per share in the first quarter of fiscal 2014.
Luminex Earnings Beat but Fall Y/Y, Shares Down - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 05, 9:34AM CST
The decline in earnings can be attributable to lower revenues and higher costs during the quarter.
Abiomed to Present at the Leerink Global Healthcare Conference 2014
GlobeNewswire - Wed Feb 05, 7:00AM CST
Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer will present at the Leerink Global Healthcare Conference 2014, February 12 at 1:00 p.m. EST. The conference will be held at The Waldorf Astoria Hotel in New York City, New York.
Medical Technology Veterans Program is renamed the MedTech and BioTech Veterans Program (MVP) and Expands Nationwide
GlobeNewswire - Wed Feb 05, 7:00AM CST
- Offers Advanced Educational Resources and Training for Veteran Recruits
Accuray Sees Narrower Loss, Hits 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 03, 11:57AM CST
Accuray posted a much narrower loss of $5.4 million, or 7 cents per share for the quarter compared with a loss of $25.5 million, or 35 cents per share for the same quarter in the prior fiscal year
Accuray (ARAY) Catches Eye: Stock Jumps 15.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 03, 8:04AM CST
Accuray Incorporated was a big mover last session, as the company saw its shares rise over 15% on the day.
